IL132761A0 - Crystalline macrolides and process for their preparation - Google Patents
Crystalline macrolides and process for their preparationInfo
- Publication number
- IL132761A0 IL132761A0 IL13276198A IL13276198A IL132761A0 IL 132761 A0 IL132761 A0 IL 132761A0 IL 13276198 A IL13276198 A IL 13276198A IL 13276198 A IL13276198 A IL 13276198A IL 132761 A0 IL132761 A0 IL 132761A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- macrolides
- crystalline
- crystalline macrolides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Metallurgy (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9713730.1A GB9713730D0 (en) | 1997-06-30 | 1997-06-30 | Organic compounds |
PCT/EP1998/003929 WO1999001458A1 (en) | 1997-06-30 | 1998-06-26 | Crystalline macrolides and process for their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
IL132761A0 true IL132761A0 (en) | 2001-03-19 |
Family
ID=10815103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13276198A IL132761A0 (en) | 1997-06-30 | 1998-06-26 | Crystalline macrolides and process for their preparation |
Country Status (32)
Country | Link |
---|---|
US (1) | US6423722B1 (xx) |
EP (1) | EP0994880B1 (xx) |
JP (2) | JP3880634B2 (xx) |
KR (1) | KR100399765B1 (xx) |
CN (1) | CN1139595C (xx) |
AR (1) | AR017754A1 (xx) |
AT (1) | ATE287410T1 (xx) |
AU (1) | AU739211B2 (xx) |
BR (1) | BR9810956A (xx) |
CA (1) | CA2290412C (xx) |
CO (1) | CO4940463A1 (xx) |
CZ (1) | CZ297244B6 (xx) |
DE (1) | DE69828692T2 (xx) |
DK (1) | DK0994880T3 (xx) |
ES (1) | ES2236922T3 (xx) |
GB (1) | GB9713730D0 (xx) |
HK (1) | HK1028597A1 (xx) |
HU (1) | HU227755B1 (xx) |
ID (1) | ID24897A (xx) |
IL (1) | IL132761A0 (xx) |
MY (1) | MY118718A (xx) |
NO (1) | NO312765B1 (xx) |
NZ (1) | NZ500994A (xx) |
PE (1) | PE97699A1 (xx) |
PL (1) | PL192761B1 (xx) |
PT (1) | PT994880E (xx) |
RU (1) | RU2219181C2 (xx) |
SK (1) | SK285665B6 (xx) |
TR (1) | TR199903189T2 (xx) |
TW (1) | TW552264B (xx) |
WO (1) | WO1999001458A1 (xx) |
ZA (1) | ZA985655B (xx) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9713730D0 (en) * | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
GB9826656D0 (en) | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
GB0125443D0 (en) * | 2001-10-23 | 2001-12-12 | Novartis Ag | Organic Compounds |
DE602004024417D1 (de) * | 2003-09-03 | 2010-01-14 | Glaxo Group Ltd | Neues verfahren zur herstellung von pleuromutilinderivaten |
WO2006060616A1 (en) * | 2004-12-01 | 2006-06-08 | Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg | Processes for producing crystalline macrolides |
TW200837067A (en) * | 2006-11-06 | 2008-09-16 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
US20100105724A1 (en) * | 2006-12-07 | 2010-04-29 | Helsinn Healthcare Sa | Crystalline and amorphous forms of palonosetron hydrochloride |
US9192697B2 (en) | 2007-07-03 | 2015-11-24 | Hemoteq Ag | Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis |
ES2550634T3 (es) | 2009-07-10 | 2015-11-11 | Boston Scientific Scimed, Inc. | Uso de nanocristales para un balón de suministro de fármaco |
JP5933434B2 (ja) | 2009-07-17 | 2016-06-08 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 薬剤送達バルーンの製造方法 |
WO2012031236A1 (en) | 2010-09-02 | 2012-03-08 | Boston Scientific Scimed, Inc. | Coating process for drug delivery balloons using heat-induced rewrap memory |
WO2013022458A1 (en) * | 2011-08-05 | 2013-02-14 | Boston Scientific Scimed, Inc. | Methods of converting amorphous drug substance into crystalline form |
WO2013028208A1 (en) | 2011-08-25 | 2013-02-28 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
CN105102967B (zh) | 2013-03-15 | 2018-10-12 | 生物传感器国际集团有限公司 | 雷帕霉素衍生物的纯化 |
EP3178824A1 (en) | 2015-12-08 | 2017-06-14 | Medichem, S.A. | Process for preparing pimecrolimus |
KR102592374B1 (ko) * | 2017-05-01 | 2023-10-25 | 메다 파마 게엠베하 운트 코. 카게 | 조질의 아스코마이신을 정제된 피메크롤리무스로 전환하는 방법 |
EP3741367A1 (en) | 2019-05-21 | 2020-11-25 | Premark Pharma GmbH | Treatment of ocular disease |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51118816A (en) * | 1975-04-08 | 1976-10-19 | Meiji Seika Kaisha Ltd | A process for stabilizing non-crystalloidal solid |
US4127647A (en) * | 1975-04-08 | 1978-11-28 | Meiji Seika Kaisha, Ltd. | Process for preparation of stable amorphous macrolide antibiotic solids |
GB2084580B (en) | 1980-10-01 | 1984-07-04 | Glaxo Group Ltd | Aminoalkyl furan derivative |
JP2728482B2 (ja) * | 1989-01-26 | 1998-03-18 | 協和醗酵工業株式会社 | マクロライド系抗生物質の精製法 |
DE69013305T2 (de) | 1989-07-10 | 1995-05-18 | Chemferm Vof | Stabile form von cephradin, verfahren zu dessen herstellung und darin verwendete zwischenprodukte. |
NZ235991A (en) * | 1989-11-09 | 1993-05-26 | Sandoz Ltd | Macrolide compounds and pharmaceutical compositions thereof |
IE910847A1 (en) * | 1990-03-13 | 1991-09-25 | Fisons Plc | Immunosuppressive macrocyclic compounds |
EP0480623A1 (en) * | 1990-10-11 | 1992-04-15 | Merck & Co. Inc. | New halomacrolides and derivatives having immunosuppressive activity |
US5143918A (en) * | 1990-10-11 | 1992-09-01 | Merck & Co., Inc. | Halomacrolides and derivatives having immunosuppressive activity |
JP2508949B2 (ja) | 1991-07-30 | 1996-06-19 | 味の素株式会社 | N−(トランス−4−イソプロピルシクロヘキシルカルボニル)−d−フェニルアラニンの結晶及びその製造法 |
US5247076A (en) | 1991-09-09 | 1993-09-21 | Merck & Co., Inc. | Imidazolidyl macrolides having immunosuppressive activity |
US5221740A (en) | 1992-01-16 | 1993-06-22 | American Home Products Corporation | Oxepane isomers of rapamycin useful as immunosuppressive agents |
UA41884C2 (uk) * | 1993-11-05 | 2001-10-15 | Амерікан Хоум Продактс Корпорейшн | Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів |
US5626757A (en) * | 1994-02-22 | 1997-05-06 | Advanced Separation Technologies Inc. | Macrocyclic antibiotics as separation agents |
EP0848717A1 (en) * | 1995-08-24 | 1998-06-24 | Merck & Co., Inc. | Process for the preparation of imidazolyl macrolide immunosuppressants |
GB9713730D0 (en) * | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
-
1997
- 1997-06-30 GB GBGB9713730.1A patent/GB9713730D0/en active Pending
-
1998
- 1998-06-25 CO CO98036359A patent/CO4940463A1/es unknown
- 1998-06-26 TR TR1999/03189T patent/TR199903189T2/xx unknown
- 1998-06-26 AR ARP980103094A patent/AR017754A1/es active IP Right Grant
- 1998-06-26 PT PT98936392T patent/PT994880E/pt unknown
- 1998-06-26 ID IDW991682A patent/ID24897A/id unknown
- 1998-06-26 WO PCT/EP1998/003929 patent/WO1999001458A1/en active IP Right Grant
- 1998-06-26 AT AT98936392T patent/ATE287410T1/de active
- 1998-06-26 CA CA002290412A patent/CA2290412C/en not_active Expired - Lifetime
- 1998-06-26 KR KR10-1999-7010048A patent/KR100399765B1/ko not_active IP Right Cessation
- 1998-06-26 DK DK98936392T patent/DK0994880T3/da active
- 1998-06-26 CN CNB988064677A patent/CN1139595C/zh not_active Expired - Lifetime
- 1998-06-26 JP JP50628799A patent/JP3880634B2/ja not_active Expired - Lifetime
- 1998-06-26 PL PL336719A patent/PL192761B1/pl unknown
- 1998-06-26 CZ CZ0474099A patent/CZ297244B6/cs not_active IP Right Cessation
- 1998-06-26 EP EP98936392A patent/EP0994880B1/en not_active Expired - Lifetime
- 1998-06-26 IL IL13276198A patent/IL132761A0/xx not_active IP Right Cessation
- 1998-06-26 RU RU2000101826/04A patent/RU2219181C2/ru active
- 1998-06-26 HU HU0003053A patent/HU227755B1/hu unknown
- 1998-06-26 DE DE69828692T patent/DE69828692T2/de not_active Expired - Lifetime
- 1998-06-26 BR BR9810956-1A patent/BR9810956A/pt not_active Application Discontinuation
- 1998-06-26 NZ NZ500994A patent/NZ500994A/en not_active IP Right Cessation
- 1998-06-26 AU AU85409/98A patent/AU739211B2/en not_active Expired
- 1998-06-26 SK SK1866-99A patent/SK285665B6/sk not_active IP Right Cessation
- 1998-06-26 PE PE1998000568A patent/PE97699A1/es not_active IP Right Cessation
- 1998-06-26 ES ES98936392T patent/ES2236922T3/es not_active Expired - Lifetime
- 1998-06-29 MY MYPI98002955A patent/MY118718A/en unknown
- 1998-06-29 ZA ZA985655A patent/ZA985655B/xx unknown
- 1998-07-21 TW TW087111867A patent/TW552264B/zh not_active IP Right Cessation
-
1999
- 1999-12-02 NO NO19995909A patent/NO312765B1/no not_active IP Right Cessation
-
2000
- 2000-10-17 US US09/690,404 patent/US6423722B1/en not_active Expired - Lifetime
- 2000-10-25 HK HK00106806A patent/HK1028597A1/xx not_active IP Right Cessation
-
2006
- 2006-03-01 JP JP2006055107A patent/JP4504323B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2331518B (en) | Erythromycins and process for their preparation | |
HUP0100420A3 (en) | Novel macrolides and process for preparing them | |
HUP9800208A3 (en) | Omega-cycloalkyl-prostaglandin e2-derivatives and process for preparing them | |
PL337606A1 (en) | Derivatives of erythromycin 9-oxime | |
IL125622A0 (en) | Novel erythromycin derivatives method for preparing same and use thereof as drugs | |
IL132761A0 (en) | Crystalline macrolides and process for their preparation | |
HUP9800555A3 (en) | 3,3-diphenylallylamine derivatives and process for their preparation | |
CZ20012118A3 (cs) | Způsob výroby 3-alkanoylindolu a 3-alkylindolu | |
PL324346A1 (en) | Macrolides | |
IL126839A0 (en) | Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation | |
EP0970065A4 (en) | ANTIBIOTICS AND THEIR PREPARATION PROCESS | |
EP0846697A4 (en) | PROCESS FOR THE PREPARATION OF ERYTHROMYCIN DERIVATIVES | |
AP9901454A0 (en) | Novel erythromycin derivatives method for preparing same and use thereof as drugs | |
EP1044985A4 (en) | ERYTHROMYCIN DERIVATIVES | |
EP0884322A4 (en) | PROCESS FOR THE PREPARATION OF ERYTHROMYCIN DERIVATIVES | |
AU6168294A (en) | Triplex-forming paired-ion oligonucleotides and methods for preparing and using same | |
HUP0002717A3 (en) | 13-deoxyanthracycline derivatives and processes for preparing them | |
HK1025951A1 (en) | Cephalonsporin crystals and process for their preparation | |
IL129330A (en) | Phenoxy-phenylsulfonic acid derivatives and process for their preparation | |
AU7241398A (en) | Construction element and process for its preparation | |
PL319673A1 (en) | Biphenoles preparation process | |
HUP9902905A3 (en) | Erythromycins and process for their preparation | |
GB9700851D0 (en) | Dihydrophenanthrenone derivatives and process for their preparation | |
ZA983808B (en) | Process for preparation of azithromycin | |
HUP9902893A3 (en) | 6-0-substituted erythromycin compounds and method for making same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |